…
Terragen Holdings Limited engages in the research, development, and commercialization of biological products for the agriculture sector in Australia and New Zealand. The company offers Mylo and Terragen Probiotic for Ruminants, which are animal feed supplement probiotics for cows and calves; and Great Land Plus, a bio-stimulant for the home garden market, supporting soil health, nutrient availability, and plant growth for lawns, gardens, and indoor plants. Terragen Holdings Limited was incorporated in 1996 and is based in Coolum Beach, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public disclosures indicate Terragen Holdings Ltd (ASX: TGH) focuses on biological solutions for soil health, crop productivity and environmental remediation. Long-term growth may be supported by rising demand for sustainable agricultural inputs, regulatory pressure to reduce chemical pesticides and scaling of commercial product sales. The company could appeal to investors seeking exposure to agtech and bio-based inputs if product adoption and recurring revenue develop.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Income before tax | -4.39M | -4.63M | -3.88M | -3.98M | -6.30M |
| Net income | -3.75M | -3.72M | -3.01M | -3.23M | -5.41M |
| Selling general administrative | - | 2.26M | 3.29M | 3.81M | 4.76M |
| Selling and marketing expenses | - | 1.68M | 0.08M | 0.17M | 0.51M |
| Gross profit | 0.52M | 0.79M | 2.06M | 3.21M | 2.62M |
| Reconciled depreciation | - | - | 0.36M | 0.49M | 0.61M |
| Ebit | -4.51M | -4.78M | -3.85M | -3.97M | -6.29M |
| Ebitda | -4.09M | -4.68M | -3.50M | -3.47M | -5.69M |
| Depreciation and amortization | 0.43M | 0.10M | 0.36M | 0.49M | 0.61M |
| Operating income | -4.51M | -4.78M | -3.97M | -3.97M | -6.29M |
| Other operating expenses | 5.95M | 6.40M | 6.11M | 7.35M | 9.27M |
| Interest expense | 0.04M | 0.03M | 0.03M | 0.01M | 0.01M |
| Tax provision | - | -0.91M | -0.87M | -0.74M | -0.89M |
| Interest income | - | 0.01M | 0.11M | 0.05M | 0.03M |
| Net interest income | - | - | 0.09M | 0.04M | 0.01M |
| Income tax expense | -0.64M | 0.91M | -0.87M | -0.74M | -0.89M |
| Total revenue | 1.43M | 1.62M | 2.14M | 3.28M | 2.89M |
| Total operating expenses | 5.04M | 5.57M | 6.03M | 7.28M | 8.99M |
| Cost of revenue | 0.91M | 0.82M | 0.08M | 0.06M | 0.27M |
| Total other income expense net | 0.12M | 0.15M | 0.09M | 0.06M | -0.01M |
| Net income from continuing ops | - | - | -3.01M | -3.23M | -5.41M |
| Net income applicable to common shares | - | -3.72M | -3.01M | -3.23M | -5.41M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Total assets | 10.59M | 8.12M | 6.95M | 6.35M | 9.22M |
| Intangible assets | 0.76M | 0.28M | - | 0.20M | 0.17M |
| Other current assets | 0.18M | 1.01M | 0.27M | 0.13M | 0.13M |
| Total liab | 1.09M | 1.55M | 1.63M | 1.27M | 1.46M |
| Total stockholder equity | 9.50M | 6.57M | 5.32M | 5.08M | 7.76M |
| Other current liab | 0.42M | 0.58M | 0.72M | 0.68M | 0.89M |
| Common stock | 57.88M | 51.30M | 46.90M | 43.65M | 43.00M |
| Capital stock | - | - | - | 43.65M | 43.00M |
| Retained earnings | -48.99M | -46.99M | -43.27M | -40.25M | -37.53M |
| Other liab | - | - | - | 0.05M | 0.04M |
| Other assets | - | - | 0.00M | 0.00M | 0.00M |
| Cash | 7.36M | 4.70M | 4.54M | 4.17M | 6.67M |
| Total current liabilities | 0.89M | 1.20M | 1.37M | 1.20M | 1.25M |
| Net debt | -7.09M | -3.97M | -4.00M | -3.93M | -6.34M |
| Short term debt | 0.11M | 0.42M | 0.32M | 0.22M | 0.18M |
| Short long term debt | - | - | - | 0.13M | - |
| Short long term debt total | 0.28M | 0.74M | 0.54M | 0.24M | 0.33M |
| Other stockholder equity | - | - | - | 0.00M | 2.29M |
| Property plant equipment | - | - | - | 0.48M | 0.96M |
| Total current assets | 9.19M | 6.43M | 6.06M | 5.67M | 8.09M |
| Net tangible assets | - | - | - | 4.88M | 7.59M |
| Short term investments | - | 0.11M | - | 0.13M | - |
| Net receivables | 0.68M | 0.10M | 1.06M | 0.25M | 0.23M |
| Inventory | 0.97M | 0.50M | 0.19M | 0.20M | 0.14M |
| Accounts payable | 0.36M | 0.20M | 0.34M | 0.30M | 0.19M |
| Accumulated other comprehensive income | 0.61M | 2.26M | 1.68M | 1.68M | 2.29M |
| Non currrent assets other | - | 0.61M | 0.24M | 0.00M | 0.00M |
| Non current assets total | 1.40M | 1.69M | 0.89M | 0.68M | 1.13M |
| Capital lease obligations | - | - | - | 0.11M | 0.33M |
| Long term debt total | - | - | - | 0.02M | 0.16M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Investments | - | - | -0.13M | -0.04M | -0.12M |
| Change to liabilities | - | - | - | 0.01M | -0.29M |
| Total cashflows from investing activities | -0.18M | -0.68M | -0.13M | -0.04M | -0.12M |
| Net borrowings | - | - | -0.23M | -0.27M | -0.19M |
| Total cash from financing activities | 6.12M | 3.87M | 2.82M | 0.35M | -0.05M |
| Change to operating activities | - | - | - | -0.10M | 0.16M |
| Net income | -3.75M | -3.72M | -3.01M | -3.23M | -5.41M |
| Change in cash | 2.56M | 0.16M | 0.37M | -2.50M | -4.97M |
| Begin period cash flow | 4.80M | 4.54M | 4.17M | 6.67M | 11.64M |
| End period cash flow | 7.36M | 4.70M | 4.54M | 4.17M | 6.67M |
| Total cash from operating activities | -3.38M | -3.03M | -2.32M | -2.81M | -4.80M |
| Issuance of capital stock | - | - | 3.50M | 0.73M | 0.14M |
| Depreciation | 0.43M | 0.25M | 0.36M | 0.49M | 0.61M |
| Other cashflows from investing activities | - | -0.68M | -0.11M | 0.07M | 0.06M |
| Change to inventory | -0.48M | -0.31M | -0.01M | -0.06M | -0.14M |
| Change to account receivables | 0.26M | 0.04M | -0.06M | -0.02M | 0.09M |
| Sale purchase of stock | - | 4.76M | -0.25M | -0.11M | 0.14M |
| Other cashflows from financing activities | -0.14M | -0.36M | -0.21M | -0.19M | -0.19M |
| Change to netincome | - | - | - | -0.05M | -0.04M |
| Capital expenditures | 0.12M | 0.00M | 0.02M | 0.10M | 0.18M |
| Change in working capital | -0.19M | -0.29M | 0.34M | 0.04M | 0.01M |
| Stock based compensation | - | 0.58M | - | - | - |
| Other non cash items | 0.14M | 0.15M | 0.34M | - | 4.80M |
| Free cash flow | -3.49M | -3.03M | -2.35M | -2.91M | -4.97M |
Sector: Basic Materials Industry: Agricultural Inputs
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| TGH Terragen Holdings Ltd |
- -% |
0.01 | - | - | 5.55 | 1.21 | 3.17 | -0.34 |
| NUF Nufarm Ltd |
-0.06 1.75% |
3.37 | - | 18.55 | 0.39 | 0.72 | 0.75 | 16.06 |
| CP8 Canadian Phosphate Ltd |
0.01 4.35% |
0.12 | - | - | 26.80 | 3.31 | 22.00 | -6.44 |
| MNB Minbos Resources Ltd |
- -% |
0.01 | - | - | 127.46 | 0.75 | 457.86 | -154.89 |
| RLF RLF Agtech Ltd |
- -% |
0.02 | - | - | 0.65 | 1.87 | 0.58 | -5.75 |
Terragen Holdings Limited engages in the research, development, and commercialization of biological products for the agriculture sector in Australia and New Zealand. The company offers Mylo and Terragen Probiotic for Ruminants, which are animal feed supplement probiotics for cows and calves; and Great Land Plus, a bio-stimulant for the home garden market, supporting soil health, nutrient availability, and plant growth for lawns, gardens, and indoor plants. Terragen Holdings Limited was incorporated in 1996 and is based in Coolum Beach, Australia.
| Name | Title | Year Born |
|---|---|---|
| Mr. James MacGregor Cooper | CEO, MD & Exec. Director | NA |
| Mr. Miles Brennan | CFO & Company Sec. | NA |
| Dr. Paul Schober | Advisor | NA |
| Mr. Paul Grave | Gen. Mang. of New Zealand | NA |
| Mr. Adam Davies | Head of Sales & Marketing | NA |
| Dr. Karen Jury | Head of R&D | NA |
| Dr. Paul Scott | Head of Soil Health Product Devel. | NA |
| Mr. Andrew Wollen | Head of New Product Applications Devel. | NA |
| Mr. Miles Richard Brennan | CEO, MD & Director | NA |
| Dr. Joss West | Chief Operating Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.